DIPHENHYDRAMINE HCL AND IBUPROFEN
Generic: DIPHENHYDRAMINE HCL AND IBUPROFEN
Aurohealth LLCManufacturer
ORALRoute
DIPHENHYDRAMINE HYDROCHLORIDEActive Substance
2019-02-14Original Approval
DIPHENHYDRAMINE HCL AND IBUPROFEN is FDA application ANDA210676, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Diphenhydramine HCl oral solution, USP, 25 mg/10 mL UD, packaged in a) 10 mL unit dose cups (NDC 0121-0978-10), b) 100-ccGMP deviations: Temperature abuse
Class II2021-03-15
Banophen Diphenhydramine HCl 25 mg Antihistamine 100 capsules NDC 0904-5306-60 Distributed by: Major Pharmaceuticals 31CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Top Reported Reactions
1
OFF LABEL USE
11,583 reports
2
FATIGUE
8,714 reports
3
HEADACHE
8,192 reports
4
DRUG INEFFECTIVE
8,163 reports
5
NAUSEA
7,461 reports
6
PAIN
7,173 reports
7
INFUSION RELATED REACTION
6,244 reports
8
ARTHRALGIA
5,896 reports
9
TOXICITY TO VARIOUS AGENTS
5,617 reports
10
DYSPNOEA
5,542 reports